I agree that this site is using cookies. You can find further informations here.
X
Dogan, Mutlu
363  results:
Search for persons X
?
1

Treatment outcomes and prognostic factors in patients with ..:

Kahraman, Seda ; Karakaya, Serdar ; Kaplan, Muhammed Ali...
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Prognostic factors in non-metastatic HER2 'low' and HER2 'n..:

Türkel, Alper ; Doğan, Mutlu ; Sertesen, Elif...
Wiener klinische Wochenschrift.  136 (2024)  11-12 - p. 340-346 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Higher TP53 somatic mutation prevalence from liquid biopsy ..:

Erdem, Haktan Bağış ; Alay, Mustafa Tarık ; Özdemir, Zeynep...
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis.  828 (2024)  - p. 111847 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Uncommon variants detected via hereditary cancer panel and ..:

Özdemir, Zeynep ; Çevik, Ezgi ; Öksüzoğlu, Ömür Berna Çakmak...
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.  827 (2023)  - p. 111831 , 2023
Link: https://doi.org/10.1016/..
 
?
5

The Potential Prognostic Marker TyG Index Predicts Time to ..:

Karadag, Ibrahim ; Karakaya, Serdar ; Akkan, Tolga...
Cancer Management and Research.  15 (2023)  - p. 311-317 , 2023
Link: https://doi.org/10.2147/..
 
?
6

Gemcitabine-associated digital necrosis in metastatic breas..:

Türkel, Alper ; Özdemir, Mustafa ; Kurtuluş, Aziz.
Journal of Oncology Pharmacy Practice.  29 (2023)  7 - p. 1770-1775 , 2023
Link: https://doi.org/10.1177/..
 
?
7

Is the serum level of survivin, an antiapoptotic protein, a..:

Demirci, Nebi Serkan ; Çavdar, Eyyüp ; Erdem, Gokmen Umut...
Medicine.  102 (2023)  25 - p. e34014 , 2023
Link: https://doi.org/10.1097/..
 
?
8

Correction: Intervention for Hepatic and Pulmonary Metastas..:

Soran, Atilla ; Ozbas, Serdar ; Ozcinar, Beyza...
Annals of Surgical Oncology.  30 (2022)  2 - p. 1074-1074 , 2022
Link: https://doi.org/10.1245/..
 
?
9

Easier and more explanatory indices by integrating leukocyt..:

Paydas, Semra ; Lacin, Sahin ; Dogan, Mutlu...
Leukemia Research.  107 (2021)  - p. 106586 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Assessment of Prognostic Factors and Adjuvant Treatment Mod..:

Akagündüz, Baran ; Akin Telli, Tugba ; Sezgin Goksu, Sema...
Cureus.  , 2021
Link: https://doi.org/10.7759/..
 
?
11

Platelet-to-lymphocyte Ratio (PLR) as an Indicator of Survi..:

Eraslan, Emrah ; Doğan, Mutlu
Medical Science and Discovery.  8 (2021)  4 - p. 283-288 , 2021
Link: https://doi.org/10.36472..
 
?
12

IPS-3 Validation in 1012 cases with classical hodgkin lymph..:

Paydas, Semra ; Laçin, Sahin ; Doğan, Mutlu...
Leukemia Research.  102 (2021)  - p. 106519 , 2021
Link: https://doi.org/10.1016/..
 
?
13

The Relationship Between Plexin C1 Overexpression and Survi..:

NazimTurhal, Serdar ; Dogan, Mutlu ; Esendagli, Guldal...
Journal of Gastrointestinal Cancer.  53 (2021)  2 - p. 356-362 , 2021
Link: https://doi.org/10.1007/..
 
?
14

"Swords and Shields" against COVID-19 for patients with can..:

Karacin, Cengiz ; Acar, Ramazan ; Bal, Oznur...
Supportive Care in Cancer.  29 (2021)  8 - p. 4587-4593 , 2021
Link: https://doi.org/10.1007/..
 
?
15

The Effect of Primary Surgery in Patients with De Novo Stag..:

Soran, Atilla ; Dogan, Lutfi ; Isik, Arda...
Annals of Surgical Oncology.  28 (2021)  9 - p. 5048-5057 , 2021
Link: https://doi.org/10.1245/..
 
1-15